Pd-l1 inhibitors for the treatment of prostate cancer

ANTONIO LOPEZ BELTRAN2026-01-292026-01-29202010.2174/13894501216662006091422192-s2.0-85094980776https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/32512Clinical BiochemistryDrug DiscoveryMolecular MedicinePharmacologyPd-l1 inhibitors for the treatment of prostate cancerother